CorMedix Inc.
General ticker "CRMD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $774.4M (TTM average)
CorMedix Inc. does not follow the US Stock Market performance with the rate: -20.3%.
Estimated limits based on current volatility of 1.6%: low 8.20$, high 8.47$
Factors to consider:
- Total employees count: 83 (+102.4%) as of 2023
- Top business risk factors: Operating losses and capital needs, Regulatory and compliance, Dependence on key management, Strategic risks and growth management, Operational and conduct risks
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.83$, 15.78$]
- 2026-12-31 to 2027-12-31 estimated range: [8.60$, 15.43$]
Financial Metrics affecting the CRMD estimates:
- Positive: with PPE of 6.9 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 20.03 > 12.90
- Positive: Operating profit margin, % of 48.17 > 18.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Return on assets ratio (scaled to [-100,100]) of 16.48 > 6.06
- Negative: Investing cash flow per share per price, % of -35.29 <= -14.17
- Negative: negative Industry operating income (median)
Short-term CRMD quotes
Long-term CRMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $43.47MM | $311.71MM |
| Operating Expenses | $48.96MM | $65.83MM | $161.57MM |
| Operating Income | $-48.96MM | $-22.36MM | $150.14MM |
| Non-Operating Income | $2.62MM | $3.03MM | $-0.12MM |
| Interest Expense | $0.03MM | $0.04MM | $2.78MM |
| R&D Expense | $13.16MM | $3.94MM | $19.33MM |
| Income(Loss) | $-46.34MM | $-19.32MM | $150.02MM |
| Taxes | $0.00MM | $-1.40MM | $-13.04MM |
| Net Income(Loss)* | $-46.34MM | $-17.93MM | $163.06MM |
| Stockholders Equity | $70.14MM | $84.66MM | $405.31MM |
| Inventory | $2.11MM | $7.60MM | $29.72MM |
| Assets | $82.06MM | $118.85MM | $826.14MM |
| Operating Cash Flow | $-38.41MM | $-50.61MM | $175.05MM |
| Capital expenditure | $0.33MM | $0.12MM | $2.26MM |
| Investing Cash Flow | $-17.06MM | $21.23MM | $-308.43MM |
| Financing Cash Flow | $55.92MM | $26.32MM | $238.45MM |
| Earnings Per Share** | $-0.91 | $-0.30 | $2.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.